2015
DOI: 10.1016/j.bios.2014.09.026
|View full text |Cite
|
Sign up to set email alerts
|

Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
261
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 475 publications
(263 citation statements)
references
References 115 publications
1
261
0
Order By: Relevance
“…Aptamers can be considered as artificial alternatives to antibodies, produced via chemical synthesis (Toh et al, 2015). Their in vitro selection process enables the generation of different aptamers selectively binding a huge variety of different target molecules, even toxic or low immunogenic ones (Mairal et al, 2008).…”
Section: Initial Results: Aptamer-based Detection Of C-reactive Protementioning
confidence: 99%
“…Aptamers can be considered as artificial alternatives to antibodies, produced via chemical synthesis (Toh et al, 2015). Their in vitro selection process enables the generation of different aptamers selectively binding a huge variety of different target molecules, even toxic or low immunogenic ones (Mairal et al, 2008).…”
Section: Initial Results: Aptamer-based Detection Of C-reactive Protementioning
confidence: 99%
“…29 Aptamers have the advantages of being highly specific, relatively small in size, and easily synthesized, which could be regarded as a chemical equivalent of antibodies. 30,31 In this study, we adopted a truncated aptamer A10-3.2 with 39 nucleotides for its simplicity of chemical synthesis and enhanced specificity. It is about 55% of the full A10 in size.…”
Section: Discussionmentioning
confidence: 99%
“…Aptamers have functions similar to those of antibodies, but they can be easily synthesized and conveniently preserved. Therefore, aptamers have an application potential as substitutes of antibodies in clinical diagnosis and disease treatment 1, 2, 3, 4, 5, 6, 7, 8. However, in fundamental research and clinical diagnosis, relevant applications are still dominated by monoclonal antibodies, and aptamer diagnostics is in the experimental stage, because the aptamer screening efficiency of the classical systematic evolution of ligands by exponential enrichment (SELEX) technology is relatively low 9, 10, and high‐quality aptamers are not easily available.…”
Section: Introductionmentioning
confidence: 99%